dc.creator | Bruder, Marjorie | |
dc.creator | Vendramini-Costa, Débora Barbosa | |
dc.creator | de Carvalho, João Ernesto | |
dc.creator | Pilli, Ronaldo Aloise | |
dc.date | 2013-Sep | |
dc.date | 2015-11-27T13:31:59Z | |
dc.date | 2015-11-27T13:31:59Z | |
dc.date.accessioned | 2018-03-29T01:18:12Z | |
dc.date.available | 2018-03-29T01:18:12Z | |
dc.identifier | Bioorganic & Medicinal Chemistry. v. 21, n. 17, p. 5107-17, 2013-Sep. | |
dc.identifier | 1464-3391 | |
dc.identifier | 10.1016/j.bmc.2013.06.044 | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/23876338 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/200741 | |
dc.identifier | 23876338 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1300974 | |
dc.description | The present work describes the preparation of a novel series of compounds based on the structure of goniothalamin (1), a natural styryl lactone with known cytotoxic and antiproliferative activities against a variety of cancer cell lines. A focused library of 17 goniothalamin analogues displaying the 5-methyl-2,5-dihydrofuran-2-one motif were prepared, and their cytotoxicity evaluated. While the analogues bearing methoxy and/or hydroxy groups on the aromatic moiety usually were at least three times less potent than the lead compound (1), ortho and para-trifluoromethyl analogues 10 and 11 exhibited levels of cytotoxicity similar to goniothalamin (1) against most cancer cell lines evaluated. One could suggest that the electronic effect of the trifluoromethyl group activates the inhibitor's electrophilic site via reduction of the electron density of the α,β-unsaturated ester oxygen atom. These results provide new information on the structure activity relationship of these α,β-unsaturated styryl lactones, thereby further focusing the design of novel candidates. | |
dc.description | 21 | |
dc.description | 5107-17 | |
dc.language | eng | |
dc.relation | Bioorganic & Medicinal Chemistry | |
dc.relation | Bioorg. Med. Chem. | |
dc.rights | fechado | |
dc.rights | Copyright © 2013 Elsevier Ltd. All rights reserved. | |
dc.source | PubMed | |
dc.subject | Antineoplastic Agents | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cell Survival | |
dc.subject | Drug Design | |
dc.subject | Drug Screening Assays, Antitumor | |
dc.subject | Furans | |
dc.subject | Ht29 Cells | |
dc.subject | Humans | |
dc.subject | K562 Cells | |
dc.subject | Mcf-7 Cells | |
dc.subject | Pyrones | |
dc.subject | Structure-activity Relationship | |
dc.subject | 2,5-dihydrofuran-2-ones | |
dc.subject | Antiproliferative Activity | |
dc.subject | Cancer Cells | |
dc.subject | Goniothalamin | |
dc.title | Design, Synthesis And In Vitro Evaluation Against Human Cancer Cells Of 5-methyl-5-styryl-2,5-dihydrofuran-2-ones, A New Series Of Goniothalamin Analogues. | |
dc.type | Artículos de revistas | |